Disclosure Of Entity's Operating Segments [Text Block]

Xspray Pharma - Filing #690674

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Disclosure of entity's operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue	—	—	—	– SEK	—	—	—	—	—	—	– SEK	—
Tax expense (income)	—	—	—	– SEK	—	—	—	—	—	—	– SEK	—
Profit (loss) before tax	—	—	—	131 670 SEK	—	—	—	—	—	—	96 698 SEK	—
Profit (loss)	—	– SEK	– SEK	131 670 SEK	131 670 SEK	– SEK	—	– SEK	– SEK	– SEK	96 698 SEK	96 698 SEK
Assets	585 430 SEK	—	—	—	—	—	622 903 SEK	—	—	—	—	—
Cash flows from (used in) operating activities	—	—	—	110 179 SEK	—	—	—	—	—	—	51 607 SEK	—
Cash flows from (used in) investing activities	—	—	—	135 345 SEK	—	—	—	—	—	—	105 818 SEK	—
Cash flows from (used in) financing activities	—	—	—	93 809 SEK	—	—	—	—	—	—	103 708 SEK	—
Disclosure of products and services [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of major customers [abstract]
Disclosure of major customers [line items]